Status: current, Defined. Date: 31-Oct 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4622221000168119 | Erlotinib (Cipla) (erlotinib 100 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4622231000168116 | Erlotinib (Cipla) 100 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Erlotinib (Cipla) 100 mg tablet | Is a | Erlotinib (Cipla) | true | Inferred relationship | Some | ||
| Erlotinib (Cipla) 100 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Erlotinib (Cipla) 100 mg tablet | Is a | erlotinib 100 mg tablet | true | Inferred relationship | Some | ||
| Erlotinib (Cipla) 100 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Erlotinib (Cipla) 100 mg tablet | has Australian BoSS | erlotinib | true | Inferred relationship | Some | 1524179039 | |
| Erlotinib (Cipla) 100 mg tablet | has intended active ingredient | erlotinib | true | Inferred relationship | Some | 1524179039 | |
| Erlotinib (Cipla) 100 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 880946050 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Erlotinib (Cipla) 100 mg tablet, 30 | has TPUU | True | Erlotinib (Cipla) 100 mg tablet | Inferred relationship | Some | 2076722863 |
| Erlotinib (Cipla) 100 mg tablet, 30, blister pack | has TPUU | True | Erlotinib (Cipla) 100 mg tablet | Inferred relationship | Some | 537864268 |
Reference Sets
Trade product unit of use reference set
FHIR